Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-label extension study for patients with severe chronic lower back pain or severe chronic pain due to osteoarthritis of the knee who have completed any of the previous clinical trials of phase IIIb tapentadol hydrochloride KF5503/42 codes, KF5503/43, KF5503/44 or KF5503 / 45. [Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb de clorhidrato de tapentadol códigos KF5503/42, KF5503/43, KF5503/44 o KF5503/45.]

Next Previous
Trial Profile

Open-label extension study for patients with severe chronic lower back pain or severe chronic pain due to osteoarthritis of the knee who have completed any of the previous clinical trials of phase IIIb tapentadol hydrochloride KF5503/42 codes, KF5503/43, KF5503/44 or KF5503 / 45. [Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb de clorhidrato de tapentadol códigos KF5503/42, KF5503/43, KF5503/44 o KF5503/45.]

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tapentadol (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Grunenthal

Most Recent Events

  • 09 Jun 2011 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top